Skip to content
OpenCapital
Get started

Pulmonx Corporation LUNG Cash & Equivalents

Cash & Equivalents at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
$2.05B-21.6%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$288.1M+160%
Savara logo
SavaraSVRA
$38.79M+98.4%
LQD
Liquidia CorporationLQDA
$222.79M+31.2%
United Therapeutics logo
United TherapeuticsUTHR
$1.28B-32.6%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$9.76M-3.9%

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-47.3%
Enterprise value$50.17M-43.5%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:Cash.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's cash & equivalents?
Pulmonx Corporation (LUNG) reported cash & equivalents of $61.03M in Q1 2026.
How has Pulmonx Corporation's cash & equivalents changed year-over-year?
Pulmonx Corporation's cash & equivalents decreased by 2.4% year-over-year, from $62.54M to $61.03M.
What is the long-term trend for Pulmonx Corporation's cash & equivalents?
Over 5 years (2020 to 2025), Pulmonx Corporation's cash & equivalents has grown at a -20.8% compound annual growth rate (CAGR), from $221.03M to $68.71M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.